Johnson & Johnson (XTER:JNJ) Net Interest Margin (Bank Only) %


XTER:JNJ Johnson & Johnson XTER:JNJ
86 GF Score
Price €229.85
GF Value €165.49
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XTER:JNJ
86GF Score
Johnson & Johnson XTER:JNJ
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Johnson & Johnson (XTER:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of €229.85 is trading 38.9% above its estimated GF Value™ of €165.49. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for XTER:JNJ:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €165.49 vs. price of €229.85 (38.9% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the XTER:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
86GF Score

Get the complete analysis for XTER:JNJ

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€229.85
Price
€165.49
GF Value